The mechanisms promoting the global alteration of energy metabolism in the muscle of patients affected with a neuromuscular disease, best exemplified by the dramatic increase in the β-F1-ATPase/LDH-A ratio (Table 1), has remained largely unexplained. This evidence concerns the gene LDHA and neuromuscular disease.